RELPAX

This brand name is authorized in Austria, Australia, Canada, Germany, Spain, France, Hong Kong, Croatia, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug RELPAX contains one active pharmaceutical ingredient (API):

1 Eletriptan UNII M41W832TA3 - ELETRIPTAN HYDROBROMIDE

Eletriptan is a selective agonist at the vascular 5-HT1B and neuronal 5-HT1D receptors. Eletriptan also exhibits high affinity for the 5-HT1F receptor which may contribute to its anti-migraine mechanism of action. Read about Eletriptan

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RELPAX Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CC06	Eletriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5290K, 5291L
Country: CA	Health Products and Food Branch	Identifier(s): 02256290, 02256304
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01658658, 01658687, 03932804, 03932810, 03932827, 03932833, 03934306, 03934393, 06974714, 07005710, 09423179, 11689967, 12526902, 13332376, 13332382, 13781826, 14256789, 17448242
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64124, 64125
Country: FR	Base de données publique des médicaments	Identifier(s): 63476564, 64350636
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 146202, 34000, 34036, 374138, 381652
Country: HK	Department of Health Drug Office	Identifier(s): 66729
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-319261647
Country: IE	Health Products Regulatory Authority	Identifier(s): 54287, 72122
Country: IT	Agenzia del Farmaco	Identifier(s): 035307103, 035307281, 035307305
Country: JP	医薬品医療機器総合機構	Identifier(s): 2160005F1021
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 050M2000
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 60232
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8591, 8592, 8593
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100109142
Country: SG	Health Sciences Authority	Identifier(s): 11767P, 11768P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 14573021
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699532090881, 8699532095176, 8699532096418
Country: US	FDA, National Drug Code	Identifier(s): 0049-2330, 0049-2340, 63539-234
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/7.3/0077, 34/7.3/0078, 34/7.3/0079